A 15-year-old male, Alex, presented to his pediatrician with a three-week history of increased thirst, frequent urination, and unexplained weight loss. He reported feeling unusually fatigued and had developed blurred vision. These symptoms, while not acutely alarming, represented a significant change from his usual energetic demeanor and prompted his parents to seek medical advice. Initial blood glucose readings taken in the office were markedly elevated, prompting an urgent referral to the local hospital for further evaluation and diagnosis of Type 1 diabetes.
Upon admission, Alex underwent a series of diagnostic tests to confirm the diagnosis and assess the immediate metabolic state. His fasting blood glucose level was 380 mg/dL (normal range 70-100 mg/dL), and his hemoglobin A1c, which reflects average blood glucose over the past 2-3 months, was 11.5% (normal <5.7%). Further serological testing revealed the presence of autoantibodies, specifically glutamic acid decarboxylase (GAD65) antibodies and islet cell antibodies, confirming an autoimmune destruction of pancreatic beta cells, the hallmark of Type 1 diabetes. His serum ketone levels were slightly elevated, indicating the onset of a mild metabolic acidosis, but he did not present with diabetic ketoacidosis (DKA), a more severe complication.
The immediate treatment plan focused on achieving glycemic control and preventing DKA. Alex was initiated on a basal-bolus insulin regimen. This involved a long-acting insulin (lantus) administered once daily to provide a steady background level of insulin, and a rapid-acting insulin (novolog) taken before meals and snacks to cover carbohydrate intake. A registered dietitian provided comprehensive education on carbohydrate counting, the importance of consistent meal timing, and the role of physical activity in diabetes management. Alex and his parents were instructed on proper insulin injection technique, blood glucose monitoring using a standard glucometer, and recognizing the signs and symptoms of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar).
Long-term management for Alex will involve continuous glucose monitoring (CGM) to provide real-time glucose data and trend analysis, which can help identify patterns and improve insulin dosing. The diabetes care team, consisting of an endocrinologist, dietitian, and diabetes educator, will work with Alex and his family to adjust insulin doses based on his growth, activity levels, and dietary intake. Regular follow-up appointments will be scheduled to monitor his glycemic control, assess for any diabetes-related complications (such as retinopathy, nephropathy, and neuropathy), and provide ongoing education and support. Psychological support will also be a key component, acknowledging the significant life adjustment required to manage a chronic condition like Type 1 diabetes at his age.